Market Assessment, Social Anxiety Disorder Executive Insights Social Anxiety Disorder Executive Insights US/EU5 Report

Social Anxiety Disorder - Executive Insights - Social Anxiety Disorder | Executive Insights | US/EU5
- Social Anxiety Disorder | Executive Insights | US/EU5 | 2021

Joyce Spadafora, A.L.M.

Joyce Spadafora, A.L.M., is a senior analyst on the CNS/Ophthalmology Disorders team. She authors content on various chronic pain, psychiatric, and neurological indications. Prior to joining the company, she spent several years in the biotech industry focusing on new product development and consulting. She holds a master’s degree in extension studies in psychology from Harvard University and a bachelor’s of science in mechanical engineering with biology from the Massachusetts Institute of Technology.

Buy report Login to access report

Back to all Market Assessment reports

Contact us

Investors

Careers

Login

Social Anxiety Disorder – Executive Insights – Social Anxiety Disorder | Executive Insights | US/EU5

Table of contents

Related Market Assessment Reports

Asthma | Unmet Need | Severe Asthma | US/EU | 2021

Asthma – Unmet Need – Detailed, Expanded Analysis – Severe Asthma (US/EU)

Pulmonary Hypertension – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)

Crohn’s Disease – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis – Pediatric Crohn’s Disease (US)

Chronic Kidney Disease – Current Treatment – Detailed, Expanded Analysis – Treatment Algorithms – Claims Data Analysis (US)